Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients

被引：42

作者：

Shen, Yong ^{[1
,2
]}

Zhang, Suzhan ^{[1
,2
]}

Sun, Ren ^{[1
,2
,3
]}

Wu, Tingting ^{[1
,2
,3
]}

Qian, Jing ^{[2
,4
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc,China Natl Minist Educ,Key Lab Canc Pre, Hangzhou 310009, Zhejiang, Peoples R China

[2] Zhejiang Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, ZJU UCLA Joint Ctr Med Educ & Res, Hangzhou 310058, Zhejiang, Peoples R China

[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA

[4] Zhejiang Univ, Sch Med, Res Ctr Infect & Immun, Hangzhou 310058, Zhejiang, Peoples R China

来源：

EMERGING MICROBES & INFECTIONS | 2015年 / 4卷

基金：

中国国家自然科学基金;

关键词：

adaptive immunity; EBV; immune evasion; innate immunity; NPC; NASOPHARYNGEAL CARCINOMA-CELLS; REGULATORY T-CELLS; MEMBRANE-PROTEIN; NF-KAPPA-B; ANTIGEN-PROCESSING FUNCTION; BURKITTS-LYMPHOMA CELLS; CLASS-II EXPRESSION; COMPLEX CLASS-I; DENDRITIC CELLS; LATENT MEMBRANE-PROTEIN-1;

D O I：

10.1038/emi.2015.20

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Epstein-Barr virus (EBV) has been used as a paradigm for studying host-virus interactions, not only because of its importance as a human oncogenic virus associated with several malignancies including nasopharyngeal carcinoma (NPC) but also owing to its sophisticated strategies to subvert the host antiviral responses. An understanding of the interplay between EBV and NPC is critical for the development of EBV-targeted immunotherapy. Here, we summarize the current knowledge regarding the host immune responses and EBV immune evasion mechanisms in the context of NPC.

引用

页数：9

共 50 条

[41] Epstein-Barr virus in patients with infectious endocarditis
Zhiburt, EB
Serebryanaya, NB
Dyakova, VV
Khubulava, GG
Shikhverdiev, NN
Katkova, IV
TERAPEVTICHESKII ARKHIV, 1997, 69 (04) : 42 - 43
[42] ANTIBODIES TO EPSTEIN-BARR VIRUS IN PATIENTS WITH CRYPTOCOCCOSIS
LEVINE, PH
DIAMOND, RD
REISHER, JI
JOURNAL OF CLINICAL MICROBIOLOGY, 1975, 1 (04) : 363 - 365
[43] Epstein-Barr virus in patients with immunodeficiency disorders
Okano, M
BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (07) : 353 - 361
[44] EPSTEIN-BARR VIRUS IN PATIENTS WITH CHRONIC HEPATITIS
SCHOENBAUM, E
RADENSKY, P
CASTELLAR, L
SCHAFFNER, F
HEPATOLOGY, 1983, 3 (05) : 862 - 862
[45] Epstein-Barr virus infection in patients with MOGAD
Maniscalco, Giorgia T.
Dinoto, Alessandro
Foglia, Maria C.
Di Battista, Maria E.
Moreggia, Ornella
Di Giulio Cesare, Daniele
Williams, Michela
Rossi, Francesca W.
Carta, Sara
Chiodega, Vanessa
Ferrari, Sergio
Viola, Assunta
de Paulis, Amato
Andreone, Vincenzo
Mariotto, Sara
MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (01) : 117 - 120
[46] Epstein-Barr virus infection in patients with vitiligo
Grimes, PE
Elkadi, T
Sanders, J
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 604 - 604
[47] Epstein-Barr virus infection in patients with MOGAD
Maniscalco, Giorgia Teresa
Dinoto, Alessandro
Foglia, Maria
Di Battista, Maria Elena
Moreggia, Ornella
Cesare, Daniele Di Giulio
Williams, Michela
Rossi, Francesca Wanda
Carta, Sara
Chiodega, Vanessa
Ferrari, Sergio
Viola, Assunta
de Paulis, Amato
Andreone, Vincenzo
Mariotto, Sara
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1184 - 1185
[48] CORRELATION BETWEEN ALLERGY AND PERSISTENT EPSTEIN-BARR VIRUS-INFECTIONS IN CHRONIC-ACTIVE EPSTEIN-BARR VIRUS-INFECTED PATIENTS
OLSON, GB
KANAAN, MN
GERSUK, GM
KELLEY, LM
JONES, JF
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 78 (02) : 308 - 314
[49] CONTROL OF INDUCTION OF EPSTEIN-BARR VIRUS BY HOST-CELL
GLASER, R
NONOYAMA, M
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 12 - 12
[50] HOST RESPONSES TO EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN LEPROSY
PAPAGEORGIOU, PS
SOROKIN, CF
KOUZOUTZAKOGLOU, K
BONFORTE, RJ
WORKMAN, PL
GLADE, PR
INFECTION AND IMMUNITY, 1973, 7 (04) : 620 - 624

← 1 2 3 4 5 →